"When cardiac molecular imaging data from the FMT was combined with MRI imaging, the researchers were able to create a fused molecular and anatomical imaging map of the heart to identify and quantify biomarkers of monocyte activity in vivo."

— Jeffrey Peterson, PhD, VP of Applied Biology at VisEn Medical, describing how his company's imaging technology has been used to generate data enabling scientists to discover a new biologic pathway, "VisEn technology enables 'key' scientific discovery."